Andrew D Rule Selected Research

Percutaneous Nephrolithotomy

10/2013	Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification.
1/2013	Effect of age on the clinical presentation of incident symptomatic urolithiasis in the general population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew D Rule Research Topics

Disease

29	Chronic Renal Insufficiency 01/2023 - 12/2004
21	Hypertension (High Blood Pressure) 10/2023 - 06/2005
14	Kidney Calculi (Kidney Stone) 01/2023 - 01/2010
12	Acute Kidney Injury (Acute Renal Failure) 12/2023 - 11/2012
10	Neoplasms (Cancer) 01/2024 - 10/2017
9	Critical Illness (Critically Ill) 12/2023 - 05/2017
9	Obesity 01/2020 - 04/2009
9	Chronic Kidney Failure (Chronic Renal Failure) 01/2017 - 04/2009
8	Kidney Diseases (Kidney Disease) 01/2024 - 06/2006
7	Inflammation (Inflammations) 03/2024 - 10/2007
7	Urinary Tract Infections (Urinary Tract Infection) 01/2023 - 06/2005
7	Fibrosis (Cirrhosis) 10/2022 - 11/2011
6	Proteinuria 01/2023 - 10/2013
5	Atrophy 10/2022 - 01/2016
5	Heart Failure 01/2021 - 04/2009
4	Lymphoma (Lymphomas) 11/2023 - 01/2018
4	Nephrosclerosis 10/2023 - 01/2016
4	Pathologic Constriction (Stenosis) 10/2022 - 10/2019
4	Albuminuria 01/2019 - 10/2007
3	Chronic Disease (Chronic Diseases) 02/2024 - 08/2021
3	Renal Insufficiency (Renal Failure) 01/2024 - 03/2005
3	Arteriosclerosis 10/2022 - 09/2011
3	Urinary Calculi (Urinary Calculus) 01/2022 - 01/2010
3	Primary Hyperoxaluria (Oxaluria, Primary) 02/2021 - 08/2011
3	Diabetes Mellitus 11/2018 - 02/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 03/2017 - 04/2009
3	Hypertrophy 07/2016 - 11/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2016 - 05/2009
3	Shock 01/2013 - 01/2011
2	Cysts 01/2024 - 05/2012
2	Hematuria 01/2023 - 12/2014
2	Ischemia 01/2023 - 11/2012
2	COVID-19 10/2021 - 01/2021
2	Nephrocalcinosis 02/2021 - 11/2020
2	Drug-Related Side Effects and Adverse Reactions 03/2020 - 01/2018
2	Malnutrition (Nutritional Deficiencies) 01/2019 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019 - 01/2018
2	Alcoholism (Alcohol Abuse) 03/2017 - 04/2009
2	Dyslipidemias (Dyslipidemia) 03/2017 - 04/2009
2	Gout 03/2017 - 04/2009
2	Solitary Kidney 07/2013 - 09/2012
2	Hydronephrosis 07/2013 - 09/2012
2	Neurogenic Urinary Bladder (Bladder, Neurogenic) 07/2013 - 09/2012
2	Insulin Resistance 08/2009 - 10/2007
2	Essential Hypertension 07/2009 - 07/2006
2	Lower Urinary Tract Symptoms 06/2005 - 03/2005
1	Pathologic Processes 01/2023
1	Sclerosis 01/2023

Drug/Important Bio-Agent (IBA)

39	CreatinineIBA 12/2023 - 12/2004
17	Cystatin CIBA 12/2023 - 03/2012
13	AlbuminsIBA 10/2019 - 06/2006
12	Biomarkers (Surrogate Marker)IBA 02/2024 - 11/2011
11	Uric Acid (Urate)IBA 10/2023 - 08/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 11/2023 - 10/2018
5	CalciumIBA 01/2022 - 10/2009
5	Iothalamic Acid (Iotalamic Acid)FDA Link 01/2020 - 12/2004
5	StruviteIBA 01/2019 - 01/2010
4	Cefepime (Maxipime)FDA LinkGeneric 11/2023 - 06/2021
4	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 01/2018
4	beta-LactamsIBA 01/2023 - 03/2021
4	Phenobarbital (Luminal)FDA Link 10/2022 - 10/2019
4	Proteins (Proteins, Gene)FDA Link 02/2021 - 12/2016
4	Vancomycin FDA LinkGeneric 12/2020 - 05/2017
4	Calcium OxalateIBA 11/2020 - 10/2014
3	Meropenem (Merrem)FDA LinkGeneric 12/2023 - 06/2021
2	Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric 01/2022 - 06/2021
2	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 01/2021 - 11/2011
2	Indicators and Reagents (Reagents)IBA 01/2019 - 02/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 11/2012
2	Troponin T (Troponin T1)IBA 01/2016 - 11/2015
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 06/2013
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2016 - 01/2016
2	Dihydrotachysterol (AT 10)IBA 11/2015 - 12/2014
2	CytokinesIBA 09/2013 - 10/2007
2	C-Reactive ProteinIBA 06/2013 - 10/2007
2	HDL CholesterolIBA 04/2011 - 10/2007
2	AngiotensinsIBA 10/2007 - 07/2006
1	A 19IBA 03/2024
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Dietary CalciumIBA 01/2022
1	PotassiumIBA 01/2022
1	Phytic Acid (Inositol Hexaphosphate)IBA 01/2022
1	SirtuinsIBA 10/2021
1	CeramidesIBA 10/2021

Therapy/Procedure

10	Nephrectomy 01/2024 - 10/2017
7	Therapeutics 01/2019 - 07/2009
5	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2023 - 07/2013
4	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2013 - 01/2011
3	Extracorporeal Membrane Oxygenation 12/2023 - 11/2023
3	Transplantation 09/2021 - 01/2016
3	Renal Dialysis (Hemodialysis) 03/2016 - 10/2012
3	Liver Transplantation 07/2015 - 08/2014
3	Urinary Diversion (Ileal Conduit) 07/2013 - 01/2010
2	Kidney Transplantation 01/2024 - 01/2023
2	Aftercare (After-Treatment) 12/2023 - 05/2023
2	Catheters 04/2015 - 10/2012
2	Percutaneous Nephrolithotomy 10/2013 - 01/2013
1	Drug Therapy (Chemotherapy) 11/2023
1	CARE protocol 05/2023
1	Patient Transfer (Patient Dumping) 05/2023